HB-adMSCs

autologous adipose-derived mesenchymal stem cells · Hope Biosciences Research Foundation

Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for HB-adMSCs, covering 2022-03-22 to 2026-06-10. Get the full timeline:

Most recent: Clinical Trial Results: Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD) [Phase 2]